rucaparib in platinum-sensitive ovarian cancer
Published 6 years ago • 229 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
5:11
defining rucaparib’s value in recurrent ovarian cancer
-
6:49
platinum-sensitive relapsed ovarian cancer: rucaparib
-
4:20
rucaparib explored for high-risk ovarian cancer
-
1:41
the clinical activity of rucaparib in patients with ovarian cancer
-
4:25
rucaparib: clinical activity in relapsed ovarian cancer
-
3:06
rucaparib maintenance therapy for high-risk ovarian cancer
-
3:11
rucaparib in recurrent ovarian cancer: ariel3 trial
-
2:58
rucaparib for relapsed ovarian cancer: safety profile
-
2:25
results of niraparib/bevacizumab combo in platinum-sensitive recurrent ovarian cancer
-
6:51
platinum sensitivity and parp inhibition in ovarian cancer
-
9:05
case 4: recurrent ovarian cancer, platinum-resistant, brca wt
-
1:21
rucaparib may improve pfs in patients with ovarian cancer
-
1:42
phase iii results for rucaparib in ovarian cancer
-
2:15
toxicities associated with rucaparib for the treatment of ovarian cancer
-
1:13
comparison of trials of niraparib, olaparib and rucaparib in ovarian cancer
-
3:59
case 3: recurrent ovarian cancer, platinum-sensitive, brca wt
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
2:31
should all platinum sensitive patients recieve parp inhibitors?
-
4:07
approaching platinum-refractory recurrent ovarian cancer